% Expired Patents = 30.0

CIPO Patents = 2

EPO Patents = 2

Forward Citations = 23

Loading Chart...

7 inventors (with patents filed for the assignee):

Frank Tegtmeier (10 out of 12 patents)

Peter Scheurer (7 out of 7 patents)

Reinhard Schinzel (7 out of 7 patents)

4. Robert Doblhofer (3 out of 4 patents)

5. Ulrich Walter (1 out of 4 patents)

6. Kirstin Wingler (1 out of 1 patent)

7. Harald Schmidt (1 out of 5 patents)

10 patents: Sort by Forward Citations

1. 12458644 - Process for preparing solutions comprising biopterin derivatives (2025-11-04),

2. 11717522 - Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions (2023-08-08),

3. 10925877 - Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions (2021-02-23),

4. 10493075 - Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions (2019-12-03),

5. 10016431 - Solid pharmaceutical compositions comprising biopterin derivatives and uses of suchcompositions (2018-07-10),

6. 9895372 - Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions (2018-02-20),

7. 9422289 - Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species (2016-08-23),

8. 9382252 - Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species (2016-07-05),

9. 8236809 - Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activation (2012-08-07),

10. 7541360 - 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level (2009-06-02),

Company Overview

Vasopharm GmbH is a biopharmaceutical company based in Wuerzburg, Germany, specializing in the development of innovative therapies for critical care and neurological disorders. The company focuses on advancing treatments that target vascular and neuroprotective mechanisms, aiming to improve patient outcomes in conditions such as traumatic brain injury and stroke. With a commitment to research and development, Vasopharm collaborates with academic institutions and industry partners to bring novel solutions to the healthcare market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#6 in Wuerzburg

#3,752 in Germany

#56,047 in the World

Wuerzburg, Germany

Vasopharm Gmbh

Forward Citations = 23

7 inventors:

Frank Tegtmeier (10 out of 12 patents)

Peter Scheurer (7 out of 7 patents)

Reinhard Schinzel (7 out of 7 patents)

4. Robert Doblhofer (3 out of 4 patents)

5. Ulrich Walter (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vasopharm Gmbh. Retrieved from https://idiyas.com/company/vasopharm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]